Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

1. Catumaxomab

   James E. Frampton

   Sharh maqolaNanoparticle-Based Drug DeliveryDrugs20121 iqtibos

   ABIABI:AkademIndex/openalex/2012.review-article.000001

2. Catumaxomab: First Approval

   Yahiya Y. Syed

   Sharh maqolaCancer therapeutics and mechanismsDrugs20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000255